Recent News Roth MKM Bullish Stance Drives Insmed Toward Massive Projected Revenue Growth By 2026 The biopharmaceutical sector is witnessing a significant shift in sentiment regarding Insmed Incorporated as financial analysts begin to price in the long by Josh Weiner 3 hours ago